STAT+: Key study of Grail’s cancer detection test fails in setback for company
Stat News • 2/19/2026 – 2/20/2026
Summary
Grail's blood test for early cancer detection did not meet its main goal in a large study conducted with England’s NHS. This represents a setback for the company.
Advertisement
Lindy Score Breakdown (V4.2)
48d
Age
1
Sources
from cluster
1145
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1145/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1145/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 48 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Many cancer patients don’t get genomic tests to guide treatment, study finds
Stat News • 1 day ago
STAT+: Research revealing how the brain flushes waste named STAT Madness Editors’ Pick
Stat News • 1 day ago
STAT+: University of Michigan wins 2026 STAT Madness for new insights into abdominal aortic aneurysms
Stat News • 1 day ago
STAT+: How a four-month FDA delay forced a small biotech company to close its doors
Stat News • 2 days ago
STAT+: FDA backs proposals to entice pharma companies to test, make drugs domestically
Stat News • 1 day ago
Opinion: STAT+: Former Geisinger CEO: U.S. health systems must replace huge numbers of people with AI
Stat News • 1 day ago
STAT+: Terns’ drug may not be as competitive as many initially thought
Stat News • Today
STAT+: Novo Nordisk launches high-dose Wegovy
Stat News • 1 day ago
STAT+: Stealth biotech Stipple bets on secretive ADCs
Stat News • 2 days ago
STAT+: Health insurers score major win with higher 2027 Medicare Advantage rates
Stat News • 2 days ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about Trump tariff plans, FDA’s OK for a Lilly obesity pill, and more
Stat News • 6 days ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 2 weeks ago
STAT+: Trump administration prepares 100% tariffs on some imported drugs
Stat News • 6 days ago
STAT+: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along
Stat News • 5 days ago
STAT+: White House proposes 12% cut to federal health agencies in 2027 budget request
Stat News • 5 days ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 2 weeks ago
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 1 week ago